How Useful Are Surrogate Endpoints In Securing Reimbursement Of Cancer Drugs?

 
• By Ian Schofield
  
Australian dollars
A new report looks at the impact of surrogate outcomes on drug funding decisions • Source: Shutterstock

More from Health Technology Assessment

More from Market Access